Moreover, insulin modulates BCAA transamination in type 2 diabetes [32] and BCAT2 activity [33], suggesting that insulin resistance could lead to an accumulation of BCKAs due to defects in both BCAA transamination and oxidation. Here, BCAT2 is linked to type 2 diabetes mellitus.